Commentary on “Opioid Prescribing Patterns Among Facial Plastic and Reconstructive Surgeons in the Medicare Population” by Barbarite et al: Shorter Duration Opioid Prescribing After Surgery—Moving Needles or Goalposts?
Restricted accessArticle commentaryFirst published online December, 2021
Commentary on “Opioid Prescribing Patterns Among Facial Plastic and Reconstructive Surgeons in the Medicare Population” by Barbarite et al: Shorter Duration Opioid Prescribing After Surgery—Moving Needles or Goalposts?
BarbariteEMJ, HadlockT, LeeL, ShayeD, GadkareeS. Opioid prescribing patterns among facial plastic and reconstructive surgeons in the Medicare population. Facial Plast Surg Aesthet Med. 2021; 23(6):401–405.
2.
JandaliD, BarreraJE. Equivocal pain scores one week after rhinoplasty: synthetic opioid versus neuropathic analgesic. Facial Plast Surg Aesthet Med. 2020 [Epub ahead of print]; DOI: 10.1089/fpsam.2020.0350.
3.
GadkareeSK, ShayeDA, OcchiogrossoJ, LeeLN. Association between pain and patient satisfaction after rhinoplasty. JAMA Facial Plast Surg. 2019; 21(6):475–479.
4.
EggerstedtM, StensonKM, RamirezEA, et al.Association of perioperative opioid-sparing multimodal analgesia with narcotic use and pain control after head and neck free flap reconstruction. JAMA Facial Plast Surg. 2019; 21(5):446–451.
5.
YalamanchiP, ThomasWW, WorkmanAD, et al.Value of intensive care unit-based postoperative management for microvascular free flap reconstruction in head and neck surgery. Facial Plast Surg Aesthet Med. 2021; 23(1):49–53.
